Coherus Oncology (CHRS) Goodwill (2014 - 2023)

Coherus Oncology has disclosed Goodwill across 10 years of filings, most recently posting $943000.0 for Q4 2023.

• Goodwill for Q4 2023 came in at $943000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2023 was $943000.0 (changed 0.0% YoY), and the FY2023 annual result was $943000.0, changed 0.0% from the prior year.
• Goodwill came in at $943000.0 for Q4 2023 at Coherus Oncology, roughly flat from $943000.0 in the prior quarter.
• In the past five years, Goodwill ranged from a high of $943000.0 in Q1 2019 to a low of $900000.0 in Q4 2021.
• The 5-year median for Goodwill is $943000.0 (2019), against an average of $940133.3.
• Across the five-year window, Goodwill decreased 4.56% in 2021 and increased 4.78% in 2022, its largest moves.
• Coherus Oncology's Goodwill stood at $943000.0 in 2019, then changed by 0.0% to $943000.0 in 2020, then declined by 4.56% to $900000.0 in 2021, then increased by 4.78% to $943000.0 in 2022, then changed by 0.0% to $943000.0 in 2023.
• The last three Goodwill figures came in at $943000.0 (Q4 2023), $943000.0 (Q3 2023), and $943000.0 (Q4 2022), per Business Quant data.